ストックスクリーナーアプリを入手
1.17
1.74%
0.02
アフターアワーズ：
1.16
-0.01
-0.85%
前日終値:
$1.15
開ける：
$1.16
24時間の取引高:
34,954
Relative Volume:
0.46
時価総額：
$4.11M
収益：
$1.31M
当期純損益:
$-7.56M
株価収益率:
-0.1137
EPS:
-10.2926
ネットキャッシュフロー:
$-8.25M
1週間 パフォーマンス:
+22.38%
1か月 パフォーマンス:
+3.54%
6か月 パフォーマンス:
-24.52%
1年 パフォーマンス:
-78.96%
1日の値動き範囲:
$1.12
$1.17
1週間の範囲:
$0.94
$1.20
52週間の値動き範囲:
$0.84
$8.62
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
名前
60 Degrees Pharmaceuticals Inc
セクター
電話
202-327-5422
住所
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, MRNA, ARGX, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.17 | 4.11M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc (SXTP) 最新ニュース
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus - Investing.com
SXTP: Label expansion for ARAKODA into babesiosis advances, with pivotal milestones expected by 2028 - TradingView
60 Degrees Pharmaceuticals at H.C. Wainwright: babesiosis push in focus By Investing.com - Investing.com India
SXTP: Label expansion for ARAKODA into babesiosis aims for regulatory milestones and launch by 2028 - TradingView
Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – BOATS:SXTPW - TradingView
60 Degrees Pharmaceuticals Flags Cash Runway Only Into Early October - minichart.com.sg
60 Degrees Pharmaceuticals Updates Strategy for Tick-Borne Diseases - TipRanks
60 Degrees Pharmaceuticals updates investor presentation outlining tafenoquine babesiosis sNDA path, Q2 results and July financing - TradingView
60 Degrees Pharma flags going-concern risk - Stock Titan
60 Degrees Pharmaceuticals to Present at H.C. Wainwright 28th Annual Global Investment Conference - Quiver Quantitative
60 Degrees Pharmaceuticals Announces Participation in H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
A pharmaceutical company will post a public presentation Sept. 11. Its management will meet investors in New York. - Stock Titan
60 DEGREES PHARMACEUTICALS, INC. SEC Filing (Aug 26, 2026) - Stock Titan
Degrees (SXTP) Q1 2026 Earnings: The EPS Result Is Below Expectation in the Latest Reading; Stock Move: The Stock Finishes Near Unchanged in Latest TradingRevenue Warning Signal - careplusvn.com
Degrees (SXTP) Snapshot: Closes with Little Net Change at $1.13 at the Close; Next Test: Price Remains Between $1.07 Support and $1.19 Resistance in the Current UpdateSentiment Divergence - vinanet.vn
Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn
Analysts’ Opinions Are Mixed on These Healthcare Stocks: OmniAb (OABI), Bicycle Therapeutics (BCYC) and 60 Degrees Pharmaceuticals, Inc. (SXTP) - The Globe and Mail
H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo
SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet
SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn
60 Degrees Pharmaceuticals (SXTP) Edges Higher by 1.27% as Shares Test Key Resistance at $1.26Bollinger Band - vinanet.vn
60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan
60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade
ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan
60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan
60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Stock News Today - TradingKey
60 Degrees Pharmaceuticals Shareholders Approve Key Governance Actions - The Globe and Mail
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals (NASDAQ: SXTP) reports 2026 shareholder vote outcomes - Stock Titan
Lind Global Fund III (SXTP) discloses 5.45% stake with warrant conversion cap - Stock Titan
60 Degrees Pharmaceuticals Completes Private Placement to Raise Capital - TipRanks
60 Degrees Pharmaceuticals Raises $1.0 Million in Private Placement of Stock and Warrants - tradingview.com
60 Degrees Pharmaceuticals (NASDAQ: SXTP) raises $1M in warrant-backed private placement - Stock Titan
60 Degrees Pharmaceuticals issues Series A, Series B warrants exercisable at $1.49 in $1 million private placement - Bitget
SXTP Q1 2026 Earnings: Wider-Than-Expected Loss of $1.28 Per Share Sends Stock Down 16.11%Surprise Factor Analysis - careplusvn.com
60 Degrees Pharmaceuticals raises $1M in private placement By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals, Inc. Announces Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
60 Degrees Pharmaceuticals Announces Minimum Enrollment - GlobeNewswire
60 Degrees Pharmaceuticals Inc (SXTP) Balance Sheet - TradingKey
60 Degrees Pharmaceuticals Secures US Patent for Tafenoquine Lung Infection Treatment - scanx.trade
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SXTP|60 Degrees Pharmaceuticals Inc|Price:1.140| - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SXTP Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Revenue Remains UnreportedShare Dilution Risk - careplusvn.com
60 Degrees Pharmaceuticals (SXTP) Edges Lower as Stock Tests Key Support LevelsAscending Triangle - careplusvn.com
60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTP - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) 財務データ
収益
当期純利益
現金流量
EPS
3.06%
2.55%
大文字化:
|
ボリューム (24 時間):